Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study
| Autor: | Konecny, Gottfried E, Finkler, Neil, Garcia, Agustin A, Lorusso, Domenica, Lee, Paula S, Rocconi, Rodney P, Fong, Peter C, Squires, Matt, Mishra, Kaushal, Upalawanna, Allison, Wang, Yongyu, Kristeleit, Rebecca |
|---|---|
| Zdroj: | In The Lancet Oncology June 2015 16(6):686-694 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|